Serum concentrations of estrogens, sex hormone-binding globulin, and androgens and risk of breast cancer in postmenopausal women

International Journal of Cancer

Volumn 119, Issue 10, 2006, Pages 2402-2407

  Adly, Laila ^a   Hill, Deirdre ^b,c   Sherman, Mark E ^b   Sturgeon, Susan R ^d   Fears, Thomas ^b   Mies, Carolyn ^e   Ziegler, Regina G ^b   Hoover, Robert N ^b   Schairer, Catherine ^b  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MASSACHUSETTS   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Androgens; Androstenediol; Breast cancer; Estrogens

Indexed keywords

ANDROGEN; ANDROSTENEDIONE; ESTRADIOL; ESTROGEN; ESTRONE; ESTRONE SULFATE; PRASTERONE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; AGED; ANDROGEN BLOOD LEVEL; ARTICLE; BREAST BIOPSY; BREAST CANCER; CANCER RISK; ESTROGEN BLOOD LEVEL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MASTECTOMY; POSTMENOPAUSE; PRIORITY JOURNAL; UNITED STATES;

AGED; ANDROGENS; ANDROSTENEDIOL; BREAST NEOPLASMS; DEHYDROEPIANDROSTERONE; ESTROGENS; ESTRONE; FEMALE; HUMANS; MIDDLE AGED; ODDS RATIO; POSTMENOPAUSE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE;

EID: 33749648116     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.22203     Document Type: Article

References (33)

1. Henderson BE, Feigelson HS. Hormonal carcinogenesis. Carcinogenesis 2000;21:427-33.
2. The Endogenous Hormones and Breast Cancer Collaborative Group. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 2002; 94:606-16.
3. Lillie EO, Bernstein L, Ursin G. The role of androgens and polymorphisms in the androgen receptor in the epidemiology of breast cancer. Breast Cancer Res 2003;5:164-73.
4. Klevjer-Anderson P, Buehring GC. Effect of hormones on growth rates of malignant and nonmalignant human mammary epithelia in cell culture. In Vitro 1980;16:491-501.
5. Birrell SN, Bentel JM, Hickey TE, Ricciardelli C, Weger MA, Horsfall DJ, Tilley WD. Androgens induce divergent proliferative responses in human breast cancer cell lines. J Steroid Biochem Mol Biol 1995;52:459-67.
6. Zava DT, McGuire WL. Estrogen receptors in androgen-induced breast tumor regression. Cancer Res 1977;37:1608-10.
7. Dorgan JF, Stanczyk FZ, Longcope C, Stephenson HE, Jr, Chang L, Miller R, Franz C, Falk RT, Kahle L. Relation of serum dehydroepiandrosterone (DHEA), DHEA sulfate, and 5-androstene-3β,17 β-diol to risk of breast cancer in postmenopausal women. Cancer Epidemiol Biomark Prev 1997;6:177-81.
8. Schairer C, Hill D, Sturgeon SR, Fears T, Pollak M, Mies C, Ziegler RG, Hoover RN, Sherman ME. Serum concentrations of IGF-I, IGFBP-3 and c-peptide and risk of hyperplasia and cancer of the breast in postmenopausal women. Int J Cancer 2004;108:773-9.
9. Masnyk IJ, Sera M, Corle D, Go VLW, Dunsmore M. Serum bank for biological markers for breast cancer. J Natl Cancer Inst 1983;71: 875-6.
10. Fitzgibbons PL, Henson DE, Hutter RVP. Benign breast changes and the risk for subsequent breast cancer: an update of the 1985 consensus statement. Arch Pathol Lab Med 1998;122:1053-5.
11. Fears TR, Ziegler RG, Donaldson JL, Falk RT, Hoover RN, Stanczyk FZ, Vaught JB, Gail MH. Reproducibility studies and interlaboratory concordance for androgen assays in female plasma. Cancer Epidemiol Biomark Prev 2000;9:403-12.
12. Dorgan JF, Longcope C, Stephenson HE, Jr, Falk RT, Miller R, Franz C, Kahle L, Campbell WS, Tangrea JA, Schatzkin A. Relation of pre-diagnostic serum estrogen and androgen levels to breast cancer risk. Cancer Epidemiol Biomark Prev 1996;5:533-9.
13. Thomas HV, Key TJ, Allen DS, Moore JW, Dowsett M, Fentiman IS, Wang DY. A prospective study of endogenous serum hormone concentrations and breast cancer risk in post-menopausal women on the island of Guernsey. Br J Cancer 1997;76:401-5.
14. Hankinson SE, Willett WC, Manson J, Colditz GA, Hunter DJ, Spiegelman D, Barbieri RL, Speizer FE. Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 1998;90:1292-9.
15. Toniolo PG, Levita M, Zeleniuch-Jacquotte A, Banerjee S, Koenig KL, Shore RE, Strax P, Pasternak BS. A prospective study of endogenous estrogens and breast cancer in postmenopausal women. J Natl Cancer Inst 1995;87:190-7.
16. Zeleniuch-Jacquotte A, Bruning PF, Bonfrer JMG, Koenig KL, Shore RE, Kim MY, Pasternack BS, Toniolo P. Relation of serum levels of testosterone and dehydroepiandrosterone sulfate to risk of breast cancer in postmenopausal women. Am J Epidemiol 1997;145:1030-8.
17. Berrino F, Muti P, Micheli A, Bolelli G, Krogh V, Sciajno R, Pisani P, Panico S, Secreto G. Serum sex hormone levels after menopause and subsequent breast cancer. J Natl Cancer Inst 1996;88:291-6.
18. Barrett-Connor E, Friedlander NJ, Khaw K-T. Dehydroepiandrosterone sulfate and breast cancer risk. Cancer Res 1990;50:6571-4.
19. Garland CF, Friedlander NJ, Barrett-Connor E, Khaw K-T. Sex hormones and postmenopausal breast cancer: a prospective study in an adult community. Am J Epidemiol 1992;135:1220-30.
20. Kabuto M, Akiba S, Stevens RG, Neriishi K, Land CE. A prospective study of estradiol and breast cancer in Japanese women. Cancer Epidemiol Biomark Prev 2000;9:575-9.
21. Cauley JA, Lucas FL, Kuller LH, Stone K, Browner W, Cummings SR. Elevated serum estradiol and testosterone concentrations are associated with a higher risk for breast cancer. Ann Intern Med 1999;130: 270-7.
22. Gordon GB, Bush TL, Helzlsouer KJ, Miller SR, Comstock GW. Relationship of serum levels of dehydroepiandrosterone and dehydroepiandrosterone sulfate to the risk of developing postmenopausal breast cancer. Cancer Res 1990;50:3859-62.
23. Helzlsouer KJ, Alberg AJ, Bush TL, Longcope C, Gordon GB, Comstock GW. A prospective study of endogenous hormones and breast cancer. Cancer Detect Prev 1994;18:79-85.
24. Zeleniuch-Jacquotte A, Shore RE, Koenig KL, Akhmedkhanov A, Afanasyeva Y, Kato I, Kim MY, Rinaldi S, Kaaks R, Toniolo P. Postmenopausal levels of oestrogen, androgen, and SHBG and breast cancer: long-term results of a prospective study. Br J Cancer 2004;90: 153-9.
25. Missmer SA, Eliassen H, Barbieri RL, Hankinson SE. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women. J Natl Cancer Inst 2004;96: 1856-65.
26. Manjer J, Johansson R, Berglund G, Janzon L, Kaaks R, Agren A, Lenner P. Postmenopausal breast cancer risk in relation to sex steroid hormones, prolactin and SHBG (Sweden). Cancer Causes Control 2003;14:599-607.
27. Kaaks R, Rinaldi S, Key TJ, Berrino F, Peeters PHM, Biessy C, Dossus L, Lukanova A, Bingham S, Khaw K-T, Allen NE, Bueonde-Mesquita HB, et al. Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition. Endocr Relat Cancer 2005;12: 1071-82.
28. Yu H, Shu X-O, Shi R, Dai Q, Jin F, Gao Y-T, Li BDL, Zheng W. Plasma sex steriod hormones and breast cancer risk in Chinese women. Int J Cancer 2003;105:92-7.
29. Micheli A, Muti P, Pisani P, Secreto G, Recchione C, Totis A, Fissi R, Cavalleri A, Panico S, Berrino F. Repeated serum and urinary androgen measurements in premenopausal and postmenopausal women. J Clin Epidemiol 1991;44:1055-61.
30. Toniolo P, Koenig KL, Pasternack BS, Banerjee S, Rosenberg C, Shore RE, Strax P, Levitz M. Reliability of measurements of total, protein-bound, and unbound estradiol in serum. Cancer Epidemiol Biomark Prev 1994;3:47-50.
31. Cauley JA, Gutai JP, Kuller LH, Powell JG. Reliability and interrelations among serum sex hormones in postmenopausal women. Am J Epidemiol 1991;133:50-7.
32. Hankinson SE, Manson JE, Spiegelman D, Willett WC, Longcope C, Speizer FE. Reproducibility of plasma hormone levels in postmenopausal women over a 2-3-year period. Cancer Epidemiol Biomark Prev 1995;4:649-54.
33. Panico S, Pisani P, Muti P, Recchione C, Cavalleri A, Totis A, Berrino F. Diurnal variation of testosterone and estradiol: a source of bias in comparative studies on breast cancer. J Endocrinol Invest 1990;13:423-6.